Clinical Significance and Characteristics of Newly Detected Lesions on Breast MRI During Neoadjuvant Chemotherapy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate clinical significance and imaging findings of newly detected lesions on breast MRI while monitoring patients’ response to neoadjuvant chemotherapy (NAC). Materials and Methods: We identified 291 patients with newly diagnosed breast cancer who underwent breast MRI to assess their response to NAC between January 2017 and August 2021. We evaluated 26 new lesions in 24 women (mean age, 49.8 years; range, 35–63 years) who were included in this study. Two radiologists assessed imaging findings of new lesions according to Breast Imaging Reporting and Data System (BI-RADS) lexicon 5th edition and evaluated follow-up MRI during NAC. Outcomes of new lesions were determined based on pathologic examination or imaging follow-up after surgery. Results: All 26 new lesions were found on the first follow-up imaging. They disappeared or decreased in size on the second follow-up imaging. Lesion types included mass (n = 22, 84.6%) and non-mass enhancement (n = 4, 15.4%). The majority of the mass types showed oval to round shapes (22/22, 100%), circumscribed margins (21/22, 95.5%), and rim enhancement (18/22, 81.8%). Seven (26.9%) new lesions were ipsilateral to the index cancer, 7 (26.9%) were contralateral, and 12 (46.2%) were bilateral. None of these new lesions were malignant. Conclusion: New lesions were detected in 4.7% of breast MRI during NAC. Most new lesions tended to be oval, circumscribed, or rim-enhancing masses. None of these new lesions were malignant.
Abstract
Purpose: This study aimed to evaluate clinical significance and imaging findings of newly detected lesions on breast MRI while monitoring patients’ response to neoadjuvant chemotherapy (NAC). Materials and Methods: We identified 291 patients with newly diagnosed breast cancer who underwent breast MRI to assess their response to NAC between January 2017 and August 2021. We evaluated 26 new lesions in 24 women (mean age, 49.8 years; range, 35–63 years) who were included in this study. Two radiologists assessed imaging findings of new lesions according to Breast Imaging Reporting and Data System (BI-RADS) lexicon 5th edition and evaluated follow-up MRI during NAC. Outcomes of new lesions were determined based on pathologic examination or imaging follow-up after surgery. Results: All 26 new lesions were found on the first follow-up imaging. They disappeared or decreased in size on the second follow-up imaging. Lesion types included mass (n = 22, 84.6%) and non-mass enhancement (n = 4, 15.4%). The majority of the mass types showed oval to round shapes (22/22, 100%), circumscribed margins (21/22, 95.5%), and rim enhancement (18/22, 81.8%). Seven (26.9%) new lesions were ipsilateral to the index cancer, 7 (26.9%) were contralateral, and 12 (46.2%) were bilateral. None of these new lesions were malignant. Conclusion: New lesions were detected in 4.7% of breast MRI during NAC. Most new lesions tended to be oval, circumscribed, or rim-enhancing masses. None of these new lesions were malignant.
참고문헌 (21)
- Tomida K, "Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations", Mol Clin Oncol, 2, pp.783~788 (2014)
- Mieog JS, "Neoadjuvant chemotherapy for operable breast cancer", Br J Surg, 94, pp.1189~1200 (2007)
- Rastogi P, "Preoperative chemotherapy : updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27", J Clin Oncol, 26, pp.778~785 (2008)
- King TA, "Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy", Nat Rev Clin Oncol, 12, pp.335~343 (2015)
- Chen M, "Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer", Chin Med J(Engl), 125, pp.1862~1866 (2012)
- Davis PL, "Sensitivity of enhanced MRI for the detection of breast cancer: new, multicentric, residual, and recurrent", Eur Radiol, 7(Suppl 5), pp.S289~S298 (1997)
- Partridge SC, "Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy", AJR Am J Roentgenol, 179, pp.1193~1199 (2002)
- Yeh E, "Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer", AJR Am J Roentgenol, 184, pp.868~877 (2005)
- Eckstein DA, "Frequency and outcomes of new suspicious lesions on breast MRI in the setting of neoadjuvant therapy", AJR Am J Roentgenol, 216, pp.633~639 (2021)
- Sørlie T, "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications", Proc Natl Acad Sci U S A, 98, pp.10869~10874 (2001)
- Sorlie T, "Repeated observation of breast tumor subtypes in independent gene expression data sets", Proc Natl Acad Sci U S A, 100, pp.8418~8423 (2003)
- Hugh J, "Breast cancer subtypes and response to docetaxel in node-positive breast cancer : use of an immunohistochemical definition in the BCIRG 001 trial", J Clin Oncol, 27, pp.1168~1176 (2009)
- Choo JR, "Biomarkers for basal-like breast cancer", Cancers(Basel), 2, pp.1040~1065 (2010)
- Kim SI, "Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer", Oncology, 79, pp.324~330 (2010)
- Liberman L, "Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size", AJR Am J Roentgenol, 186, pp.426~430 (2006)
- Bick U, "Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging", Insights Imaging, 11, pp.12~ (2020)
- Bates T, "Litigation for pneumothorax as a complication of fine-needle aspiration of the breast", Br J Surg, 89, pp.134~137 (2002)
- Luengo-Gil G, "Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis", Breast Cancer Res Treat, 151, pp.577~587 (2015)
- Jain RK, "Normalizing tumor vasculature with anti-angiogenic therapy : a new paradigm for combination therapy", Nat Med, 7, pp.987~989 (2001)
- Goedegebuure RSA, "Combining radiotherapy with anti-angiogenic therapy and immunotherapy;a therapeutic triad for cancer?", Front Immunol, 9, pp.3107~ (2019)
- Olawoyin OM, "Comparison of autologous breast reconstruction complications by type of neoadjuvant chemotherapy regimen", Plast Reconstr Surg, 148, pp.1186~1196 (2021)